RhumbLine Advisers’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-29,836
| Closed | -$82K | – | 3180 |
|
|
2021
Q1 | $82K | Buy |
29,836
+100
| +0.3% | +$275 | ﹤0.01% | 2953 |
|
|
2020
Q4 | $72K | Buy |
29,736
+4,595
| +18% | +$11.1K | ﹤0.01% | 2998 |
|
|
2020
Q3 | $53K | Sell |
25,141
-8,645
| -26% | -$18.2K | ﹤0.01% | 2947 |
|
|
2020
Q2 | $128K | Sell |
33,786
-5,131
| -13% | -$19.4K | ﹤0.01% | 2914 |
|
|
2020
Q1 | $74K | Hold |
38,917
| – | – | ﹤0.01% | 2827 |
|
|
2019
Q4 | $81K | Buy |
38,917
+606
| +2% | +$1.26K | ﹤0.01% | 2892 |
|
|
2019
Q3 | $92K | Buy |
38,311
+4,811
| +14% | +$11.6K | ﹤0.01% | 2899 |
|
|
2019
Q2 | $105K | Buy |
+33,500
| New | +$105K | ﹤0.01% | 2925 |
|
|
2018
Q2 | – | Sell |
-21,661
| Closed | -$192K | – | 2951 |
|
|
2018
Q1 | $192K | Buy |
21,661
+4,576
| +27% | +$40.6K | ﹤0.01% | 2619 |
|
|
2017
Q4 | $124K | Sell |
17,085
-4,771
| -22% | -$34.6K | ﹤0.01% | 2746 |
|
|
2017
Q3 | $151K | Buy |
21,856
+330
| +2% | +$2.28K | ﹤0.01% | 2819 |
|
|
2017
Q2 | $154K | Buy |
+21,526
| New | +$154K | ﹤0.01% | 2831 |
|